Figure 5.
The comparison of traditional chemotherapy versus combined immunotherapy in second line treatment. The PFS, OS and ORR of traditional chemotherapy and combined immunotherapy in second line treatment among the whole cohorts (A), cohort with TKI-PFS < 10 months (B), and cohort with TKI-PFS > 10 months (C). ns, none sense.